HSPPC-96: a personalised cancer vaccine

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.1, Iss.3, 2001-05, pp. : 539-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunological monitoring of cancer vaccine therapy

By Nagorsen Dirk Scheibenbogen Carmen Thiel Eckhard Keilholz Ulrich

Expert Opinion on Biological Therapy, Vol. 4, Iss. 10, 2004-10 ,pp. : 1677-1684

Informa Healthcare

Access to resources Recommend Favorite

Ovarian cancer vaccine trials and tribulations

By Buckanovich Ronald J

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 103-112

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein–peptide complex-96 for the treatment of cancer

By Amato Robert J

Expert Opinion on Biological Therapy, Vol. 7, Iss. 8, 2007-08 ,pp. : 1267-1273

Informa Healthcare

Access to resources Recommend Favorite

Anti-idiotype antibody vaccine therapy for cancer

By Bhattacharya-Chatterjee Malaya Chatterjee Sunil K Foon Kenneth A

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 869-881

Informa Healthcare

Access to resources Recommend Favorite

miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells

By Guo Haizhou Li Qianping Li Weihao Zheng Tianliang Zhao Song Liu Zhangsuo

Molecular and Cellular Biochemistry, Vol. 390, Iss. 1-2, 2014-05 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite